Claimed effect · Gonadorelin (GnRH)

Does Gonadorelin (GnRH) help with fertility in hypogonadotropic hypogonadism?

B
Grade B — probable, not settled7 comparative studies, 420 men (meta-analysis); many small series · effect size: moderate
Short answerProbable, not settled. Human data exist (7 comparative studies, 420 men (meta-analysis); many small series) and mostly agree, showing a moderate effect — but too few, too small, or not yet peer-reviewed for a firm answer. In men whose hypothalamus does not produce GnRH, pulsatile gonadorelin by pump induces puberty and sperm production. Against gonadotropin injections it produced larger testes and earlier sperm, but no significant difference in the share who produced sperm, sperm counts or pregnancies; the studies are small and mostly not randomised.

What the studies show

In men whose hypothalamus does not produce GnRH, pulsatile gonadorelin by pump induces puberty and sperm production. Against gonadotropin injections it produced larger testes and earlier sperm, but no significant difference in the share who produced sperm, sperm counts or pregnancies; the studies are small and mostly not randomised.

“GnRH therapy was related to a larger testicular volume (standardized mean difference=-1.43; p=0.01) and earlier spermatogenesis (WMD=-5.30 months; p=0.004) compared to GT.”

Verbatim, from the abstractWei C, Long G, Zhang Y, et al. Spermatogenesis of male patients with congenital hypogonadotropic hypogonadism receiving pulsatile gonadotropin-releasing hormone therapy versus gonadotropin therapy: a systematic review and meta-analysis. World J Mens Health, 2021;39(4):654–665

Human trials exist and mostly agree, but there are too few of them, they are too small, or one big one is still reading out. Expect the grade to move.

  1. 1

In context

Gonadorelin is synthetic gonadotropin-releasing hormone, the ten-amino-acid signal the hypothalamus sends to make the pituitary release LH and FSH. Given in pulses by pump it restores fertility in men and women whose own signal is missing; given once it is a licensed test of pituitary function. Neither is what it is mostly sold for today: clinics add it to testosterone replacement to 'keep the testes working', a use that has never been tested in a trial. It is prohibited for male athletes.

Gonadorelin (GnRH) is licensed (diagnostic / pulsatile); trt use unstudied. Legal status differs by country — see the regulation section or the jurisdiction pages.

Questions

Is Gonadorelin (GnRH) proven to help with fertility in hypogonadotropic hypogonadism?
Not yet settled. 7 comparative studies, 420 men (meta-analysis); many small series — LYO grades it B, meaning probable but liable to change as trials read out.
What studies are behind the grade?
In men whose hypothalamus does not produce GnRH, pulsatile gonadorelin by pump induces puberty and sperm production. Against gonadotropin injections it produced larger testes and earlier sperm, but no significant difference in the share who produced sperm, sperm counts or pregnancies; the studies are small and mostly not randomised.
Is Gonadorelin (GnRH) approved for this?
Gonadorelin (GnRH) is an approved medicine (Licensed (diagnostic / pulsatile); TRT use unstudied); whether this particular outcome is a licensed indication is stated on the compound page's regulation section.

Other outcomes for Gonadorelin (GnRH)

Written and maintained by LYO Research — how pages are written and checked. Reviewed 10 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →